Clinical Trial

Vertebrobasilar Dolichoectasia Treatment With Sirolimus

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this pilot trial is to assess the efficacy of sirolimus in reducing wall enhancement in vertebrobasilar dolichoectasia(VBD) on 5 T high-resolution magnetic resonance vessel wall imaging(HR-VWI) via anti-inflammatory mechanisms, clarify the efficacy of sirolimus in delaying the progression of VBD, evaluate the safety of sirolimus in the treatment of VBD.
Trial Details
NCT Number NCT07634120
Lead Sponsor Huashan Hospital
Conditions Vertebrobasilar Dolichoectasia
Enrollment 12 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-08